Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-10

Clinical Trial Update: Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: German Parkinson Study Group (GPS) | Conditions: Progressive Supranuclear Palsy | Phase 2 | Status: COMPLETED